Prominent child psychiatrist suspends relationship with drug makers
Boston Globe, December 31, 2008
Dr. Joseph Biederman, a prominent child psychiatrist whose relationship with drug makers is under scrutiny, will temporarily suspend his ties to the pharmaceutical industry under an agreement reached with his employer, Massachusetts General Hospital. A hospital spokeswoman said that Biederman, who specializes in diagnosing and treating bipolar disorder, has withdrawn from running several industry-funded clinical trials, and that another physician will assume oversight of the research.
Most Viewed
Most Emailed
- Primary Care Docs Average More Hospital Revenue Than Specialists
- 69% of Employers Plan to Offer Healthcare Coverage After 2014
- Building a Better Healthcare Board
- Q&A: Catholic Health Initiatives' New Senior VP for Capital Finance
- CMS Seeks to 'Rapidly Reduce' Medicare Spending with $1B in Grants
- Quiet ORs Better for Patient Safety
- CMS Releases Hospital Pricing Data
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- Hospital Pricing Data Dump Won't Hurt You, Yet
- Telemedicine is Retail Health Clinics' Newest Tool
